Direct In Vivo Human Intestinal Permeability (Peff ) Determined with Different Clinical Perfusion and Intubation Methods.
暂无分享,去创建一个
Erik Sjögren | Hans Lennernäs | H. Lennernäs | E. Sjögren | David Dahlgren | Carl Roos | D. Dahlgren | C. Roos
[1] Daisuke Nakai,et al. Human small intestinal and colonic tissue mounted in the Ussing chamber as a tool for characterizing the intestinal absorption of drugs. , 2012, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.
[2] L. Salphati,et al. Evaluation of a single‐pass intestinal‐perfusion method in rat for the prediction of absorption in man , 2001, The Journal of pharmacy and pharmacology.
[3] H. Lennernäs,et al. The effect of ketoconazole on the in vivo intestinal permeability of fexofenadine using a regional perfusion technique. , 2003, British journal of clinical pharmacology.
[4] M. Kataoka,et al. Measurement of Drug Concentration in the Stomach After Intragastric Administration of Drug Solution to Healthy Volunteers: Analysis of Intragastric Fluid Dynamics and Drug Absorption , 2012, Pharmaceutical Research.
[5] G. Ecker,et al. Evidence-based approach to assess passive diffusion and carrier-mediated drug transport. , 2012, Drug discovery today.
[6] W. Wahli,et al. Regional variations in ABC transporter expression along the mouse intestinal tract. , 2004, Physiological genomics.
[7] H. Lennernäs,et al. The influence of caprate on rectal absorption of phenoxymethylpenicillin: experience from an in‐vivo perfusion in humans , 2002, The Journal of pharmacy and pharmacology.
[8] H. Lennernäs,et al. Increased understanding of intestinal drug permeability determined by the LOC-I-GUT approach using multislice computed tomography. , 2009, Molecular pharmaceutics.
[9] Rafael Gozalbes,et al. QSAR-based permeability model for drug-like compounds. , 2011, Bioorganic & medicinal chemistry.
[10] D. Kell,et al. The promiscuous binding of pharmaceutical drugs and their transporter-mediated uptake into cells: what we (need to) know and how we can do so. , 2013, Drug discovery today.
[11] Caroline A. Lee,et al. P-glycoprotein related drug interactions: clinical importance and a consideration of disease states , 2010, Expert opinion on drug metabolism & toxicology.
[12] L. Knutson,et al. A new technique for segmental jejunal perfusion in man. , 1989, The American journal of gastroenterology.
[13] K. Luthman,et al. Effect of molecular charge on intestinal epithelial drug transport: pH-dependent transport of cationic drugs. , 1999, The Journal of pharmacology and experimental therapeutics.
[14] M. Lucas,et al. The magnitude and distribution of the acid microclimate in proximal jejunum and its relation to luminal acidification , 1978, Proceedings of the Royal Society of London. Series B. Biological Sciences.
[15] Marjo Yliperttula,et al. Computational prediction of oral drug absorption based on absorption rate constants in humans. , 2006, Journal of medicinal chemistry.
[16] Hans Lennernäs,et al. Toward an increased understanding of the barriers to colonic drug absorption in humans: implications for early controlled release candidate assessment. , 2009, Molecular pharmaceutics.
[17] G. Cook. Impairment of glycine absorption by glucose and galactose in man , 1971, The Journal of physiology.
[18] J. Diamond,et al. Lithium absorption in tight and leaky segments of intestine , 2005, The Journal of Membrane Biology.
[19] G. Amidon,et al. Human Jejunal Permeability of Two Polar Drugs: Cimetidine and Ranitidine , 2001, Pharmaceutical Research.
[20] Tanya Coleman,et al. Pancreatoduodenectomy as a source of human small intestine for Ussing chamber investigations and comparative studies with rat tissue , 2011, Biopharmaceutics & drug disposition.
[21] K. Andersson,et al. Absorption of digoxin in man after oral and intrasigmoid administration studied by portal vein catheterization , 1975, European Journal of Clinical Pharmacology.
[22] Leslie Z Benet,et al. In Vivo Modulation of Intestinal CYP3A Metabolism by P-Glycoprotein: Studies Using the Rat Single-Pass Intestinal Perfusion Model , 2003, Journal of Pharmacology and Experimental Therapeutics.
[23] Martin Bergstrand,et al. PBPK models for the prediction of in vivo performance of oral dosage forms. , 2014, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.
[24] H. Lennernäs,et al. The lack of effect of induced net fluid absorption on the in vivo permeability of terbutaline in the human jejunum. , 1995, Journal of drug targeting.
[25] G. Cook. Intestinal absorption rate of L‐methionine in man and the effect of glucose in the perfusing fluid , 1972, The Journal of physiology.
[26] T. Gramatté,et al. Paracetamol absorption from different sites in the human small intestine. , 1994, British journal of clinical pharmacology.
[27] H. Schedl,et al. Absorption of L-methionine from the human small intestine. , 1968, The Journal of clinical investigation.
[28] Kazuya Nakao,et al. In silico Prediction of Human Oral Absorption Based on QSAR Analyses of PAMPA Permeability , 2009, Chemistry & biodiversity.
[29] J. Kovarik,et al. Longitudinal assessment of a P‐glycoprotein–mediated drug interaction of valspodar on digoxin , 1999, Clinical pharmacology and therapeutics.
[30] Lawrence X. Yu,et al. High-permeability criterion for BCS classification: segmental/pH dependent permeability considerations. , 2010, Molecular pharmaceutics.
[31] K. Takács-Novák,et al. Interlaboratory study of log P determination by shake-flask and potentiometric methods. , 1996, Journal of pharmaceutical and biomedical analysis.
[32] Christer Tannergren,et al. Comprehensive study on regional human intestinal permeability and prediction of fraction absorbed of drugs using the Ussing chamber technique. , 2013, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.
[33] D. Mercer,et al. Protein digestion in human intestine as reflected in luminal, mucosal, and plasma amino acid concentrations after meals. , 1973, The Journal of clinical investigation.
[34] R. Zurier,et al. Relationship between net water absorption and hexanoic acid absorption from the intact human jejunum , 1968, The American Journal of Digestive Diseases.
[35] J. Dietschy,et al. Experimental demonstration of the effect of the unstirred water layer on the kinetic constants of the membrane transport ofd-glucose in rabbit jejunum , 1980, The Journal of Membrane Biology.
[36] Robert G. Hahn,et al. Role of Variability in Explaining Ethanol Pharmacokinetics , 2003, Clinical pharmacokinetics.
[37] G. Cook. Glucose absorption kinetics in Zambian African patients with and without systemic bacterial infections , 1971, Gut.
[38] L. Benet,et al. Distinguishing between the Permeability Relationships with Absorption and Metabolism To Improve BCS and BDDCS Predictions in Early Drug Discovery , 2014, Molecular pharmaceutics.
[39] M. Zeidel,et al. Determinants of apical membrane permeabilities of barrier epithelia. , 1994, The American journal of physiology.
[40] H Lennernäs,et al. Membrane transport of drugs in different regions of the intestinal tract of the rat. , 1998, Journal of pharmaceutical sciences.
[41] H. Lennernäs,et al. The Influence of Net Water Absorption on the Permeability of Antipyrine and Levodopa in the Human Jejunum , 1994, Pharmaceutical Research.
[42] M. Hedeland,et al. Effect of erythromycin on the absorption of fexofenadine in the jejunum, ileum and colon determined using local intubation in healthy volunteers. , 2006, International journal of clinical pharmacology and therapeutics.
[43] A. Zinsmeister,et al. Relationship of motility to flow of contents in the human small intestine. , 1982, Gastroenterology.
[44] H. Lennernäs,et al. Enterohepatic Disposition of Rosuvastatin in Pigs and the Impact of Concomitant Dosing with Cyclosporine and Gemfibrozil , 2009, Drug Metabolism and Disposition.
[45] Erik Sjögren,et al. In silico predictions of gastrointestinal drug absorption in pharmaceutical product development: application of the mechanistic absorption model GI-Sim. , 2013, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.
[46] P. Dawson. Role of the intestinal bile acid transporters in bile acid and drug disposition. , 2011, Handbook of experimental pharmacology.
[47] J. Desgrosellier,et al. 4-(N,N-dipropylamino)benzaldehyde inhibits the oxidation of all-trans retinal to all-trans retinoic acid by ALDH1A1, but not the differentiation of HL-60 promyelocytic leukemia cells exposed to all-trans retinal , 2002, BMC pharmacology.
[48] H. Lennernäs,et al. Is the Jejunal Permeability in Rats Age-Dependent? , 1997, Pharmaceutical Research.
[49] S. Chaussade,et al. Metformin in the digestive tract. , 1988, Diabetes research and clinical practice.
[50] M. Perko. Duplex ultrasound for assessment of superior mesenteric artery blood flow. , 2001, European journal of vascular and endovascular surgery : the official journal of the European Society for Vascular Surgery.
[51] W. Kirch,et al. Direct demonstration of small intestinal secretion and site‐dependent absorption of the β‐blocker talinolol in humans , 1996, Clinical pharmacology and therapeutics.
[52] E. Näslund. Gastric Emptying: Comparison of Scintigraphic, Polyethylene Glycol Dilution, and Paracetamol Tracer Assessment Techniques , 2000, Scandinavian journal of gastroenterology.
[53] Gordon L. Amidon,et al. Comparison of Human Duodenum and Caco-2 Gene Expression Profiles for 12,000 Gene Sequences Tags and Correlation with Permeability of 26 Drugs , 2002, Pharmaceutical Research.
[54] T. Bamba,et al. Effects of pectin on fatty acid and glucose absorption and on thickness of unstirred water layer in rat and human intestine , 1989, Digestive Diseases and Sciences.
[55] H. Schedl. Absorption of steroid hormones from the human small intestine. , 1965, The Journal of clinical endocrinology and metabolism.
[56] A. Thomson,et al. Intestinal sugar transport. , 2006, World journal of gastroenterology.
[57] P. Dawson,et al. Bile acid transporters , 2009, Journal of Lipid Research.
[58] W. Summerskill,et al. TRANSFER OF AMMONIA IN THE HUMAN JEJUNUM. , 1965, The Journal of laboratory and clinical medicine.
[59] G. Williamson,et al. Absorption/metabolism of sulforaphane and quercetin, and regulation of phase II enzymes, in human jejunum in vivo. , 2003, Drug metabolism and disposition: the biological fate of chemicals.
[60] Kazuya Nakao,et al. QSAR study on permeability of hydrophobic compounds with artificial membranes. , 2007, Bioorganic & medicinal chemistry.
[61] A. Dawson,et al. Further studies on the perfusion method for measuring intestinal absorption in man: The effects of a proximal occlusive balloon and a mixing segment , 1970, Gut.
[62] G. Kellett. The facilitated component of intestinal glucose absorption , 2001, The Journal of physiology.
[63] Patrick J. Sinko,et al. Estimating Human Oral Fraction Dose Absorbed: A Correlation Using Rat Intestinal Membrane Permeability for Passive and Carrier-Mediated Compounds , 2004, Pharmaceutical Research.
[64] T. Xiang,et al. Influence of a Transmembrane Protein on the Permeability of Small Molecules Across Lipid Membranes , 2000, The Journal of Membrane Biology.
[65] D. Levitt,et al. Physiological measurements of luminal stirring in the dog and human small bowel. , 1990, The Journal of clinical investigation.
[66] S. Bröer,et al. Amino acid transport across mammalian intestinal and renal epithelia. , 2008, Physiological reviews.
[67] H. Ehrén,et al. Effects of luminal distension and obstruction on the intestinal circulation , 1986, Pediatric Surgery International.
[68] Charles M Mansbach,et al. Development and physiological regulation of intestinal lipid absorption. II. Dietary lipid absorption, complex lipid synthesis, and the intracellular packaging and secretion of chylomicrons. , 2007, American journal of physiology. Gastrointestinal and liver physiology.
[69] J. Wilson,et al. Surface area of the small intestine in man. , 1967, Gut.
[70] P. Dahlqvist,et al. Improved cortisol exposure-time profile and outcome in patients with adrenal insufficiency: a prospective randomized trial of a novel hydrocortisone dual-release formulation. , 2012, The Journal of clinical endocrinology and metabolism.
[71] J. Kinney,et al. Absorption of glucose from the colon and rectum. , 1967, Metabolism: clinical and experimental.
[72] P. Annaert,et al. INTESTINAL PERFUSION WITH MESENTERIC BLOOD SAMPLING IN WILD-TYPE AND KNOCKOUT MICE , 2009, Drug Metabolism and Disposition.
[73] Hans Lennernäs,et al. In Vivo Investigation in Pigs of Intestinal Absorption, Hepatobiliary Disposition, and Metabolism of the 5α-Reductase Inhibitor Finasteride and the Effects of Coadministered Ketoconazole , 2011, Drug Metabolism and Disposition.
[74] H. Lennernäs,et al. Comparison between active and passive drug transport in human intestinal epithelial (Caco-2) cells in vitro and human jejunum in vivo , 1996 .
[75] K. C. Kwan. Oral bioavailability and first-pass effects. , 1997, Drug metabolism and disposition: the biological fate of chemicals.
[76] H Lennernäs,et al. Human Jejunal Effective Permeability and Its Correlation with Preclinical Drug Absorption Models , 1997, The Journal of pharmacy and pharmacology.
[77] E. Dimagno,et al. Fate of pancreatic enzymes during small intestinal aboral transit in humans. , 1986, The American journal of physiology.
[78] G Folkers,et al. Estimation of permeability by passive diffusion through Caco-2 cell monolayers using the drugs' lipophilicity and molecular weight. , 1998, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.
[79] H. Mekhjian,et al. Colonic secretion of water and electrolytes induced by bile acids: perfusion studies in man. , 1971, The Journal of clinical investigation.
[80] H. Lennernäs,et al. Regional transport and metabolism of ropivacaine and its CYP3A4 metabolite PPX in human intestine , 2003, The Journal of pharmacy and pharmacology.
[81] C. Binkert,et al. Feasibility of small bowel flow rate measurement with MRI , 2010, Journal of magnetic resonance imaging : JMRI.
[82] M. Sherry Ku,et al. Use of the Biopharmaceutical Classification System in Early Drug Development , 2008, The AAPS Journal.
[83] T. J. Cook,et al. Spatial expression patterns of peptide transporters in the human and rat gastrointestinal tracts, Caco-2 In Vitro cell culture model, and multiple human tissues , 2001, AAPS PharmSci.
[84] H. Lennernäs,et al. Multiple transport mechanisms involved in the intestinal absorption and first‐pass extraction of fexofenadine , 2003, Clinical pharmacology and therapeutics.
[85] R. Modigliani,et al. Absorption of glucose, sodium, and water by the human jejunum studied by intestinal perfusion with a proximal occluding balloon and at variable flow rates , 1971, Gut.
[86] F. Lombardo,et al. Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings , 1997 .
[87] Bertil Abrahamsson,et al. A convenient method for local drug administration at predefined sites in the entire gastrointestinal tract: experiences from 13 phase I studies. , 2007, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.
[88] H. Lennernäs,et al. Rat Jejunal Permeability and Metabolism of μ-Selective Tetrapeptides in Gastrointestinal Fluids from Humans and Rats , 1997, Pharmaceutical Research.
[89] D. Levitt,et al. Shaking of the intact rat and intestinal angulation diminish the jejunal unstirred layer. , 1992, Gastroenterology.
[90] G. Cook. Impairment of jejunal absorption rate of carnosine by glycylglycine in man in vivo. , 1976, Gut.
[91] H. Lennernäs,et al. Investigations of the In‐vitro Metabolism of Three Opioid Tetrapeptides by Pancreatic and Intestinal Enzymes , 2000, The Journal of pharmacy and pharmacology.
[92] M. Delorenzi,et al. Changes in the transcriptional profile of transporters in the intestine along the anterior-posterior and crypt-villus axes , 2005, BMC Genomics.
[93] A. Dawson,et al. Functional differentiation of human jejunum and ileum: A comparison of the handling of glucose, peptides, and amino acids , 1974, Gut.
[94] K. Sugano. Theoretical investigation of passive intestinal membrane permeability using Monte Carlo method to generate drug-like molecule population. , 2009, International journal of pharmaceutics.
[95] Kiyohiko Sugano,et al. Prediction of human intestinal permeability using artificial membrane permeability. , 2003, International journal of pharmaceutics.
[96] H Lennernäs,et al. Human intestinal permeability. , 1998, Journal of pharmaceutical sciences.
[97] A Rostami-Hodjegan,et al. Absolute abundance and function of intestinal drug transporters: a prerequisite for fully mechanistic in vitro-in vivo extrapolation of oral drug absorption. , 2013, Biopharmaceutics & drug disposition.
[98] Leslie Z. Benet,et al. Drug Discovery and Regulatory Considerations for Improving In Silico and In Vitro Predictions that Use Caco-2 as a Surrogate for Human Intestinal Permeability Measurements , 2013, The AAPS Journal.
[99] D. Blankenhorn,et al. Transintestinal Intubation , 1955, Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine.
[100] David G Levitt,et al. PKQuest: measurement of intestinal absorption and first pass metabolism – application to human ethanol pharmacokinetics , 2002, BMC clinical pharmacology.
[101] H. Lennernäs,et al. Regional Intestinal Permeability in Rats of Compounds with Different Physicochemical Properties and Transport Mechanisms , 1997, The Journal of pharmacy and pharmacology.
[102] J. Cerda,et al. Comparative bioavailability of folate and vitamin C from a synthetic and a natural source. , 1975, The American journal of clinical nutrition.
[103] T Scior,et al. How to recognize and workaround pitfalls in QSAR studies: a critical review. , 2009, Current medicinal chemistry.
[104] P. Artursson,et al. Comparison of drug transporter gene expression and functionality in Caco-2 cells from 10 different laboratories. , 2008, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.
[105] E. Levy,et al. Short-chain fatty acids: ready for prime time? , 2006, Nutrition in clinical practice : official publication of the American Society for Parenteral and Enteral Nutrition.
[106] D. Kell,et al. Carrier-mediated cellular uptake of pharmaceutical drugs: an exception or the rule? , 2008, Nature Reviews Drug Discovery.
[107] D. Levitt. Quantitation of small intestinal permeability during normal human drug absorption , 2013, BMC Pharmacology and Toxicology.
[108] Li Di,et al. Coexistence of passive and carrier-mediated processes in drug transport , 2010, Nature Reviews Drug Discovery.
[109] Malcolm Rowland,et al. PHRMA CPCDC initiative on predictive models of human pharmacokinetics, part 5: prediction of plasma concentration-time profiles in human by using the physiologically-based pharmacokinetic modeling approach. , 2011, Journal of pharmaceutical sciences.
[110] G. Olaison,et al. Absorption Profiles for Polyethylene Glycols After Regional Jejunal Perfusion and Oral Load in Healthy Humans , 1997, Digestive Diseases and Sciences.
[111] D. Roberts,et al. Development and differentiation of the intestinal epithelium , 2003, Cellular and Molecular Life Sciences CMLS.
[112] P. Howles,et al. Development and physiological regulation of intestinal lipid absorption. III. Intestinal transporters and cholesterol absorption. , 2008, American journal of physiology. Gastrointestinal and liver physiology.
[113] G. Amidon,et al. Molecular properties of WHO essential drugs and provisional biopharmaceutical classification. , 2004, Molecular pharmaceutics.
[114] D. Millar,et al. Intestinal diffusion barrier: unstirred water layer or membrane surface mucous coat? , 1981, Science.
[115] G. Amidon,et al. Human Jejunal Permeability of Cyclosporin A: Influence of Surfactants on P-Glycoprotein Efflux in Caco-2 Cells , 2003, Pharmaceutical Research.
[116] M. Bäckström,et al. Composition and functional role of the mucus layers in the intestine , 2011, Cellular and Molecular Life Sciences.
[117] F. Ingelfinger,et al. A method for studying absorption of water and solute from the human small intestine. , 1968, Gastroenterology.
[118] D. Loo,et al. Cotransport of water by the Na+/glucose cotransporter. , 1996, Proceedings of the National Academy of Sciences of the United States of America.
[119] V. Mathan,et al. Intestinal perfusion studies in tropical sprue. 1. Amino acid and dipeptide absorption. , 1976, Gut.
[120] V. Mathan,et al. Xylose transport in the human jejunum , 1989, Digestive Diseases and Sciences.
[121] A. Falcão,et al. Optimization of a parallel artificial membrane permeability assay for the fast and simultaneous prediction of human intestinal absorption and plasma protein binding of drug candidates: application to dibenz[b,f]azepine-5-carboxamide derivatives. , 2012, Journal of pharmaceutical sciences.
[122] C. M. Wood,et al. Absorption of short-chain fatty acids by the colon. , 1980, Gastroenterology.
[123] A Rostami-Hodjegan,et al. Interplay of metabolism and transport in determining oral drug absorption and gut wall metabolism: a simulation assessment using the "Advanced Dissolution, Absorption, Metabolism (ADAM)" model. , 2010, Current drug metabolism.
[124] G. Amidon,et al. Analysis of models for determining intestinal wall permeabilities. , 1980, Journal of pharmaceutical sciences.
[125] H. Lennernäs,et al. The effect of ketoconazole on the jejunal permeability and CYP3A metabolism of (R/S)-verapamil in humans. , 1999, British journal of clinical pharmacology.
[126] D. Perrett,et al. Dipeptide absorption in man , 1972, Gut.
[127] G. Rechkemmer,et al. pH-microclimate at the luminal surface of the intestinal mucosa of guinea pig and rat , 1986, Pflügers Archiv.
[128] Yongjun Hu,et al. Significance and Regional Dependency of Peptide Transporter (PEPT) 1 in the Intestinal Permeability of Glycylsarcosine: In Situ Single-Pass Perfusion Studies in Wild-Type and Pept1 Knockout Mice , 2010, Drug Metabolism and Disposition.
[129] Hans Lennernäs,et al. Regional intestinal drug permeation: biopharmaceutics and drug development. , 2014, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.
[130] V. Andersen,et al. Human intestinal P‐glycoprotein activity estimated by the model substrate digoxin , 2007, Scandinavian journal of clinical and laboratory investigation.
[131] J. Rhodes,et al. The effect of pH and concentration on α‐methyldopa absorption in man , 1986 .
[132] Inter-relationships between the absorptions of hydrocortisone, sodium, water and actively transported organic solutes in the human jejunum , 2004, European Journal of Clinical Pharmacology.
[133] S. Masilamani,et al. Evidence for two different modes of tripeptide disappearance in human intestine. Uptake by peptide carrier systems and hydrolysis by peptide hydrolases. , 1975, The Journal of clinical investigation.
[134] H Lennernäs,et al. Jejunal permeability in humans in vivo and rats in situ: investigation of molecular size selectivity and solvent drag. , 1999, Acta physiologica Scandinavica.
[135] Jahan B. Ghasemi,et al. Quantitative structure-property relationship study of n-octanol-water partition coefficients of some of diverse drugs using multiple linear regression. , 2007, Analytica chimica acta.
[136] Anders Karlén,et al. Hydrogen bonding descriptors in the prediction of human in vivo intestinal permeability. , 2003, Journal of molecular graphics & modelling.
[137] B Agoram,et al. Predicting the impact of physiological and biochemical processes on oral drug bioavailability. , 2001, Advanced drug delivery reviews.
[138] B. Fleshler,et al. Absorption of glycine and L-alanine by the human jejunum. , 1966, The Journal of clinical investigation.
[139] G. Cook. Effect of glycylglycine and glycine on jejunal absorption rate of L‐histidine in man in vivo , 1974, The Journal of physiology.
[140] R. Modigliani,et al. The method of intraluminal perfusion of the human small intestine. 3. Absorption studies in disease. , 1973, Digestion.
[141] U. Laforenza. Water channel proteins in the gastrointestinal tract. , 2012, Molecular aspects of medicine.
[142] H Lennernäs,et al. Correlation of human jejunal permeability (in vivo) of drugs with experimentally and theoretically derived parameters. A multivariate data analysis approach. , 1998, Journal of medicinal chemistry.
[143] C. Dubray,et al. Influence of digestive secretions and food on intestinal absorption of nicardipine , 2004, European Journal of Clinical Pharmacology.
[144] S. Adibi,et al. Functional characterization of dipeptide transport system in human jejunum. , 1974, The Journal of clinical investigation.
[145] Hans Lennernäs,et al. Comparison Between Permeability Coefficients in Rat and Human Jejunum , 1996, Pharmaceutical Research.
[146] H. Lennernäs,et al. Intestinal and Hepatobiliary Transport of Ximelagatran and Its Metabolites in Pigs , 2008, Drug Metabolism And Disposition.
[147] C. M. Wood,et al. Absorption of short chain fatty acids from the human jejunum. , 1976, Gastroenterology.
[148] Hans Lennernäs,et al. The use of biopharmaceutic classification of drugs in drug discovery and development: current status and future extension , 2005, The Journal of pharmacy and pharmacology.
[149] D. Silk. Amino acid and peptide absorption in man. , 2008, Ciba Foundation symposium.
[150] M. Rongier,et al. Investigation of drug absorption from the gastrointestinal tract of man. II. Metoprolol in the jejunum and ileum. , 1985, British journal of clinical pharmacology.
[151] C. M. Wood,et al. Absorption of short-chain fatty acids from the human ileum , 1977, The American Journal of Digestive Diseases.
[152] J. Crison,et al. A Theoretical Basis for a Biopharmaceutic Drug Classification: The Correlation of in Vitro Drug Product Dissolution and in Vivo Bioavailability , 1995, Pharmaceutical Research.
[153] R. Modigliani,et al. Validation of the use of a tube with a proximal occlusive balloon for measurement of intestinal absorption in man , 1978, The American Journal of Digestive Diseases.
[154] H Lennernäs,et al. Intestinal permeability and its relevance for absorption and elimination , 2007, Xenobiotica; the fate of foreign compounds in biological systems.
[155] N. Read,et al. Effect of gastrointestinal intubation on the passage of a solid meal through the stomach and small intestine in humans. , 1983, Gastroenterology.
[156] Han van de Waterbeemd,et al. Drug bioavailability : estimation of solubility, permeability, absorption and bioavailability , 2003 .
[157] P. Raskin,et al. Effect of intravenous somatostatin on jejunal absorption of glucose, amino acids, water, and electrolytes , 1980 .
[158] P. Besnard,et al. Intestinal absorption of long-chain fatty acids: evidence and uncertainties. , 2009, Progress in lipid research.
[159] Kiyohiko Sugano,et al. Aqueous boundary layers related to oral absorption of a drug: from dissolution of a drug to carrier mediated transport and intestinal wall metabolism. , 2010, Molecular pharmaceutics.
[160] M. Rongier,et al. Intestinal Absorption of Amiodarone in Man , 1990, Journal of clinical pharmacology.
[161] H. Lennernäs,et al. Intestinal drug absorption during induced net water absorption in man; a mechanistic study using antipyrine, atenolol and enalaprilat. , 1994, British journal of clinical pharmacology.
[162] M. Johansson,et al. The gastrointestinal mucus system in health and disease , 2013, Nature Reviews Gastroenterology &Hepatology.
[163] Alex Avdeef,et al. How well can the Caco-2/Madin-Darby canine kidney models predict effective human jejunal permeability? , 2010, Journal of medicinal chemistry.
[164] G. Krejs. Effect of Somatostatin and Atropine Infusion on Intestinal Transit Time and Fructose Absorption in the Perfused Human Jejunum , 1984, Diabetes.
[165] K. Luthman,et al. Caco-2 monolayers in experimental and theoretical predictions of drug transport , 1996 .
[166] Ganapathy,et al. Is intestinal peptide transport energized by a proton gradient? , 1985, The American journal of physiology.
[167] Kairui Feng,et al. The Simcyp® Population-based ADME Simulator , 2009 .
[168] Adibi Sa. Intestinal transport of dipeptides in man: relative importance of hydrolysis and intact absorption , 1971 .
[169] S. Phillips,et al. Active and passive bile acid absorption in man. Perfusion studies of the ileum and jejunum. , 1974, The Journal of clinical investigation.
[170] Douglas B Kell,et al. Pharmaceutical drug transport: the issues and the implications that it is essentially carrier-mediated only. , 2011, Drug discovery today.
[171] G. Amidon,et al. Physiological parameters for oral delivery and in vitro testing. , 2010, Molecular pharmaceutics.
[172] G Folkers,et al. Review of theoretical passive drug absorption models: historical background, recent developments and limitations. , 1996, Pharmaceutica acta Helvetiae.
[173] H Lennernäs,et al. Oral biopharmaceutics tools - time for a new initiative - an introduction to the IMI project OrBiTo. , 2014, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.
[174] R. Shulman,et al. Effects of Timing, Sex, and Age on Site-specific Gastrointestinal Permeability Testing in Children and Adults , 2010, Journal of pediatric gastroenterology and nutrition.
[175] T. Maurer,et al. Towards a unified model of passive drug permeation I: origins of the unstirred water layer with applications to ionic permeation. , 2014, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.
[176] S. Riley,et al. Effects of a non-absorbable osmotic load on drug absorption in healthy volunteers. , 1992, British journal of clinical pharmacology.
[177] D. Choi,et al. Drug interaction between oral atorvastatin and verapamil in healthy subjects: effects of atorvastatin on the pharmacokinetics of verapamil and norverapamil , 2008, European Journal of Clinical Pharmacology.
[178] J. DeSesso,et al. Anatomical and physiological parameters affecting gastrointestinal absorption in humans and rats. , 2001, Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association.
[179] Ho-Chul Shin,et al. Why is it Challenging to Predict Intestinal Drug Absorption and Oral Bioavailability in Human Using Rat Model , 2006, Pharmaceutical Research.
[180] H Lennernäs,et al. SPR biosensor studies of the direct interaction between 27 drugs and a liposome surface: correlation with fraction absorbed in humans. , 2000, Journal of medicinal chemistry.
[181] H H USSING,et al. Active transport of sodium as the source of electric current in the short-circuited isolated frog skin. , 1951, Acta physiologica Scandinavica.
[182] Kristina Luthman,et al. Caco-2 monolayers in experimental and theoretical predictions of drug transport1PII of original article: S0169-409X(96)00415-2. The article was originally published in Advanced Drug Delivery Reviews 22 (1996) 67–84.1 , 2001 .
[183] T. Gramatté. Griseofulvin absorption from different sites in the human small intestine , 1994, Biopharmaceutics & drug disposition.
[184] H. Minami,et al. Characteristics and mechanism of glutamine-dipeptide absorption in human intestine. , 1992, Gastroenterology.
[185] M. Rongier,et al. Evaluation of the gastric absorption and emptying of drugs under various pH conditions using a simple intubation method: application to diclofenac. , 1989, British journal of clinical pharmacology.
[186] H. Lennernäs,et al. The effect of L-leucine on the absorption of levodopa, studied by regional jejunal perfusion in man. , 1993, British journal of clinical pharmacology.
[187] J. Polli,et al. Rational use of in vitro P-glycoprotein assays in drug discovery. , 2001, The Journal of pharmacology and experimental therapeutics.
[188] W. Higuchi,et al. Quantitative mechanistic studies in simultaneous fluid flow and intestinal absorption using steroids as model solutes , 1980 .
[189] Hans Lennernäs,et al. EXPERIMENTAL ESTIMATION OF THE EFFECTIVE UNSTIRRED WATER LAYER THICKNESS IN THE HUMAN JEJUNUM, AND ITS IMPORTANCE IN ORAL-DRUG ABSORPTION , 1995 .
[190] K. Kowdley,et al. Changes in Small‐Intestine Permeability with Aging , 1995, Journal of the American Geriatrics Society.
[191] H Lennernäs,et al. Jejunal permeability and hepatic extraction of fluvastatin in humans , 1996, Clinical pharmacology and therapeutics.
[192] Neil Parrott,et al. A Physiologically Based Pharmacokinetic Model of the Minipig: Data Compilation and Model Implementation , 2012, Pharmaceutical Research.
[193] L. Fändriks,et al. Surface area of the digestive tract – revisited , 2014, Scandinavian journal of gastroenterology.
[194] Hans Lennernäs,et al. Jejunal Absorption and Metabolism of R/S-Verapamil in Humans , 1998, Pharmaceutical Research.
[195] W. Geber. Quantitative measurement of blood flow in various areas of small and large intestine. , 1960, The American journal of physiology.
[196] Anette Müllertz,et al. In vitro models for the prediction of in vivo performance of oral dosage forms. , 2014, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.
[197] F. Langenbucher,et al. In vitro and in vivo deconvolution assessment of drug release kinetics from oxprenolol Oros preparations. , 1985, British journal of clinical pharmacology.
[198] Friedrich Schuler,et al. A liposomal fluorescence assay to study permeation kinetics of drug-like weak bases across the lipid bilayer. , 2014, Journal of controlled release : official journal of the Controlled Release Society.
[199] U. Klotz,et al. Site-dependent small intestinal absorption of ranitidine , 2004, European Journal of Clinical Pharmacology.
[200] G. Amidon,et al. Human Intestinal Permeability of Piroxicam, Propranolol, Phenylalanine, and PEG 400 Determined by Jejunal Perfusion , 1997, Pharmaceutical Research.
[201] D. Levitt,et al. Use of measurements of ethanol absorption from stomach and intestine to assess human ethanol metabolism. , 1997, The American journal of physiology.
[202] H. Lennernäs,et al. FIRST-PASS EFFECTS OF VERAPAMIL ON THE INTESTINAL ABSORPTION AND LIVER DISPOSITION OF FEXOFENADINE IN THE PORCINE MODEL , 2006, Drug Metabolism and Disposition.
[203] G. Amidon,et al. Oral Absorption of Peptides: The Effect of Absorption Site and Enzyme Inhibition on the Systemic Availability of Metkephamid , 1994, Pharmaceutical Research.
[204] N. Vidon,et al. Jejunal and ileal absorption of oxprenolol in man: influence of nutrients and digestive secretions on jejunal absorption and systemic availability. , 1987, British journal of clinical pharmacology.
[205] U. Hofmann,et al. Increased Absorption of Digoxin from the Human Jejunum Due to Inhibition of Intestinal Transporter-Mediated Efflux , 2007, Clinical pharmacokinetics.
[206] M. Kataoka,et al. Optimized conditions for prediction of intestinal drug permeability using Caco-2 cells. , 2000, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.
[207] B. Johnson,et al. A completely absorbed oral preparation of digoxin , 1976, Clinical pharmacology and therapy.
[208] H. Lennernäs,et al. Regional Jejunal Perfusion, a New in Vivo Approach to Study Oral Drug Absorption in Man , 1995, Pharmaceutical Research.
[209] S. Nylander,et al. Jejunal Permeability: A Comparison Between the Ussing Chamber Technique and the Single-Pass Perfusion in Humans , 1997, Pharmaceutical Research.
[210] H. Said. Intestinal absorption of water-soluble vitamins in health and disease. , 2011, The Biochemical journal.
[211] M. Barzegar-Jalali,et al. Predicting human intestinal permeability using single-pass intestinal perfusion in rat. , 2007, Journal of pharmacy & pharmaceutical sciences : a publication of the Canadian Society for Pharmaceutical Sciences, Societe canadienne des sciences pharmaceutiques.
[212] K. Luthman,et al. Evaluation of dynamic polar molecular surface area as predictor of drug absorption: comparison with other computational and experimental predictors. , 1998, Journal of medicinal chemistry.
[213] D. Azarnoff,et al. Absorption of orally given digoxin preparations. , 1972, JAMA.
[214] G. Amidon,et al. A Residence‐Time Distribution Analysis of the Hydrodynamics within the Intestine in Man during a Regional Single‐pass Perfusion with Loc‐I‐Gut: In‐vivo Permeability Estimation , 1997, The Journal of pharmacy and pharmacology.
[215] G. Amidon,et al. The effect of amiloride on the in vivo effective permeability of amoxicillin in human jejunum: experience from a regional perfusion technique. , 2002, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.